Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Follow-Up Questions
Danaher Corp (DHR) 的本益比是多少?
Danaher Corp 的本益比是 37.9513
Danaher Corp 的 CEO 是誰?
Mr. Rainer Blair 是 Danaher Corp 的 President,自 2014 加入公司。
DHR 股票的價格表現如何?
DHR 的當前價格為 $214.31,在上個交易日 increased 了 0.22%。
Danaher Corp 的主要業務主題或行業是什麼?
Danaher Corp 屬於 Life Sciences Tools & Services 行業,該板塊是 Health Care